Back to today’s briefing

Story perspectives

Immunotherapy Revolutionizes Melanoma Treatment, Experts Highlight

4/12/2025

36 8

Summary

Story summary

At the HOPA Annual Meeting 2025, Christine Barrett, PharmD, passionately explored the transformative power of neoadjuvant therapy in melanoma. She spotlighted immunotherapy's ability to boost T-cell activity ahead of surgery, referencing pivotal trials like SWOG S1801 and NADINA. Barrett also emphasized the crucial role of oncology pharmacists in navigating treatment toxicity and empowering patients through education.

1 of 1

Story summary

At the HOPA Annual Meeting 2025, Christine Barrett, PharmD, passionately explored the transformative power of neoadjuvant therapy in melanoma. She spotlighted immunotherapy's ability to boost T-cell activity ahead of surgery, referencing pivotal trials like SWOG S1801 and NADINA. Barrett also emphasized the crucial role of oncology pharmacists in navigating treatment toxicity and empowering patients through education.